Standout Papers

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Ac... 1991 2026 2002 2014 1.0k
  1. Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid) (1991)
    Raymond P. Warrell, Stanley R. Frankel et al. New England Journal of Medicine
  2. Human Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas (2005)
    Akira Nakamizo, Frank C. Marini et al. Cancer Research
  3. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. (2002)
    Matus Studeny, Frank C. Marini et al. PubMed
  4. Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia (2005)
    Michael J. Keating, Susan O’Brien et al. Journal of Clinical Oncology
  5. Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression (2009)
    Erika L. Spaeth, Jennifer L. Dembinski et al. PLoS ONE
  6. Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia (2000)
    Hagop M. Kantarjian, Susan O’Brien et al. Journal of Clinical Oncology
  7. Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging (2009)
    Shannon Kidd, Erika L. Spaeth et al. Stem Cells
  8. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction (2009)
    Ismael Samudio, Romain Harmancey et al. Journal of Clinical Investigation
  9. Convention on nomenclature for DNA cytometry (1984)
    Wolfgang Hiddemann, J. Schumann et al. Cytometry
  10. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. (2000)
    Ingo Tamm, Steven M. Kornblau et al. PubMed
  11. Bone marrow niches in haematological malignancies (2020)
    Simón Méndez‐Ferrer, Dominique Bonnet et al. Nature reviews. Cancer
  12. MDM2 inhibition: an important step forward in cancer therapy (2020)
    Marina Konopleva, Giovanni Martinelli et al. Leukemia

Immediate Impact

3 by Nobel laureates 16 from Science/Nature 73 standout
Sub-graph 1 of 18

Citing Papers

Fibroblasts in cancer: Unity in heterogeneity
2023 Standout
TIM-3 restrains anti-tumour immunity by regulating inflammasome activation
2021 StandoutNature
1 intermediate paper

Works of Michael Andreeff being referenced

Phase IB/II Study of Nivolumab in Combination with Azacytidine (AZA) in Patients (pts) with Relapsed Acute Myeloid Leukemia (AML)
2016 Nobel
Prognostic impact and targeting of CRM1 in acute myeloid leukemia
2013
and 1 more

Author Peers

Author Last Decade Papers Cites
Michael Andreeff 25506 15751 13420 987 47.2k
Donna Neuberg 14045 12077 13815 713 45.2k
Hartmut Döhner 17222 20674 7599 644 44.0k
Francis J. Giles 14728 20046 9123 778 41.0k
Brian Druker 17055 29898 10862 597 54.0k
Guillermo Garcia‐Manero 17388 29771 7292 1.5k 42.9k
H. Phillip Koeffler 22103 6990 9803 660 41.3k
Bob Löwenberg 14077 23056 7848 526 35.1k
Elihu H. Estey 15777 27135 8442 679 39.0k
Pier Giuseppe Pelicci 31361 9425 9522 526 45.1k
Marina Konopleva 15511 15161 7723 900 29.7k

All Works

Loading papers...

Rankless by CCL
2026